At a glance
- Originator Novo Nordisk
- Class Antiepileptic drugs; Neuroprotectants; Small molecules
- Mechanism of Action
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Stroke
Most Recent Events
- 03 Nov 1999 Preclinical development for Stroke in Denmark (Unknown route)